Genomma gets a cash injection
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Mexican OTC medicines and personalcare specialist Genomma Lab has secured an investment package of almost US$100 million (€85 million) to help fund the ongoing construction of a production plant in its home country.